NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
This open tender from NHS England was published in 2026. The NHS NOFE and Midlands & East Branded Medicines - Tranche A- 1 September 2026 contract.
This UK government contract opportunity is part of the public procurement process, openly available via Find a Tender.
Ask the AI assistant for deeper analysis of this scope
Important deadlines and milestones
Tender opportunity made public on Find a Tender
This is a public procurement by NHS England. All UK government contracts are publicly accessible for transparency.
This NHS England tender is open for bids. Submit your proposal via Find a Tender.
Analyze how well this tender matches your company profile and capabilities.
ocds-h6vhtk-051c98RFP.quest helps UK businesses find and win public sector tenders. Our AI platform analyzes requirements, identifies gaps, and helps craft winning proposals.
AI-powered bid management
UK procurement tools
Expert guidance
Step-by-step guide
UK tender data from Find a Tender under the Open Government Licence. Powered by RFP.quest.
I can help you understand this NHS England contract:
• Requirements and evaluation criteria • Risks and gaps analysis • Buyer and market context • Related opportunities
Ask me anything about "NHS NOFE and Midlands & East Branded Medicines - Tranche A- 1 September 2026"!
Powered by CopilotKit